Shannon A. Carty

3.1k total citations
32 papers, 847 citations indexed

About

Shannon A. Carty is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Shannon A. Carty has authored 32 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 13 papers in Oncology and 10 papers in Immunology. Recurrent topics in Shannon A. Carty's work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Immune Cell Function and Interaction (8 papers). Shannon A. Carty is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Immune Cell Function and Interaction (8 papers). Shannon A. Carty collaborates with scholars based in United States, Australia and South Korea. Shannon A. Carty's co-authors include Philip W. Hinds, Jong-Seo Lee, David M. Thomas, Denise M. Piscopo, William C. Forrester, Martha S. Jordan, Gary A. Koretzky, Gabriel M. Gutierrez, Mercy Gohil and Erietta Stelekati and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and Blood.

In The Last Decade

Shannon A. Carty

27 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shannon A. Carty United States	9	542	362	215	111	69	32	847
Sarah Wilkinson United Kingdom	13	367 0.7×	306 0.8×	354 1.6×	83 0.7×	60 0.9×	28	936
Xiaoning Mo China	18	335 0.6×	307 0.8×	268 1.2×	169 1.5×	113 1.6×	36	763
Katoh Japan	12	579 1.1×	229 0.6×	112 0.5×	179 1.6×	67 1.0×	17	841
Sybil M. Genther Williams United States	7	430 0.8×	215 0.6×	111 0.5×	94 0.8×	71 1.0×	8	781
Aslıhan Karabacak Calviello Germany	5	392 0.7×	184 0.5×	184 0.9×	63 0.6×	82 1.2×	6	719
Amy J. Petty United States	11	271 0.5×	344 1.0×	497 2.3×	88 0.8×	80 1.2×	20	854
Kelly C. Goldsmith United States	19	543 1.0×	237 0.7×	150 0.7×	165 1.5×	60 0.9×	48	911
Hakim Bouamar United States	14	427 0.8×	195 0.5×	200 0.9×	325 2.9×	61 0.9×	31	779
George S. Laszlo United States	15	435 0.8×	401 1.1×	208 1.0×	61 0.5×	48 0.7×	35	814

Countries citing papers authored by Shannon A. Carty

Since Specialization

Citations

This map shows the geographic impact of Shannon A. Carty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon A. Carty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon A. Carty more than expected).

Fields of papers citing papers by Shannon A. Carty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon A. Carty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon A. Carty. The network helps show where Shannon A. Carty may publish in the future.

Co-authorship network of co-authors of Shannon A. Carty

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon A. Carty. A scholar is included among the top collaborators of Shannon A. Carty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon A. Carty. Shannon A. Carty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weiss, J., Shannon A. Carty, & Yasmin Karimi. (2025). Molecular Pathways and Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL). Cancers. 17(14). 2314–2314.

Carty, Shannon A., et al.. (2025). Origins of T‐cell‐mediated autoimmunity in acquired aplastic anaemia. British Journal of Haematology. 206(4). 1035–1053. 1 indexed citations

Carty, Shannon A., et al.. (2024). S4545 Simultaneous Presentation of Post-Transplant Lymphoproliferative Disorder (PTLD) and Acute Cellular Rejection (ACR) in a Liver Transplant Recipient: A Therapeutic Conundrum. The American Journal of Gastroenterology. 119(10S). S2893–S2894.

Dumke, Henry, Tycel Phillips, Mark Kaminski, et al.. (2024). Outcomes and prognostic factors of patients diagnosed with relapsed/refractory primary B-cell lymphoma: A retrospective study.. Journal of Clinical Oncology. 42(16_suppl). 7081–7081.

Yang, Xi, Victoria Nachar, Shannon A. Carty, et al.. (2024). Risk Factors for Cytokine Release Syndrome in Patients Receiving Bispecific Antibodies for B-Cell Lymphoma: A Single-Center, Retrospective Cohort Study. Blood. 144(Supplement 1). 4477–4477. 2 indexed citations

Nachar, Victoria, Lydia L. Benitez, Shannon A. Carty, et al.. (2024). Risk Factors for Severe Infection in Patients Receiving Bispecific Antibody Therapies for Lymphoma. Blood. 144(Supplement 1). 3105–3105. 1 indexed citations

Phillips, Tycel, David A. Bond, Malathi Kandarpa, et al.. (2023). Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma. Blood Advances. 7(16). 4518–4527. 7 indexed citations

Carty, Shannon A.. (2023). Biological insights into the role of TET2 in T cell lymphomas. Frontiers in Oncology. 13. 1199108–1199108. 2 indexed citations

Carty, Shannon A., Carlos Murga‐Zamalloa, & Ryan A. Wilcox. (2023). SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on Target. Clinical Lymphoma Myeloma & Leukemia. 23(8). 561–574. 1 indexed citations

10.

Bresler, Scott C., Tyler D. Menge, Trilokraj Tejasvi, Shannon A. Carty, & Alexandra C. Hristov. (2022). Two cases of challenging cutaneous lymphoid infiltrates presenting in the context of COVID‐19 vaccination: A reactive lymphomatoid papulosis‐like eruption and a bona fide lymphoma. Journal of Cutaneous Pathology. 50(3). 213–219. 6 indexed citations

11.

Carty, Shannon A.. (2021). Immunology 101: fundamental immunology for the practicing hematologist. Hematology. 2021(1). 281–286. 1 indexed citations

12.

Phillips, Tycel, Alexey V. Danilov, David A. Bond, et al.. (2021). The combination of venetoclax, lenalidomide, and rituximab in patients with newly diagnosed mantle cell lymphoma induces high response rates and MRD undetectability.. Journal of Clinical Oncology. 39(15_suppl). 7505–7505. 6 indexed citations

13.

Jordan, Martha S., et al.. (2020). DNA Methylation in T-Cell Development and Differentiation. Critical Reviews in Immunology. 40(2). 135–156. 30 indexed citations

14.

Reneau, John, Sumana Devata, Ryan A. Wilcox, et al.. (2019). <p>Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy</p>. OncoTargets and Therapy. Volume 12. 8003–8014. 8 indexed citations

15.

Franzblau, Lauren E., et al.. (2018). Adult-onset hydroa vacciniforme-like lymphoma in a long-term resident of the United States. JAAD Case Reports. 4(4). 314–317. 2 indexed citations

16.

Carty, Shannon A., Mercy Gohil, Lauren B. Banks, et al.. (2017). The Loss of TET2 Promotes CD8+ T Cell Memory Differentiation. The Journal of Immunology. 200(1). 82–91. 130 indexed citations

17.

Carty, Shannon A., Gary A. Koretzky, & Martha S. Jordan. (2014). Interleukin-4 Regulates Eomesodermin in CD8+ T Cell Development and Differentiation. PLoS ONE. 9(9). e106659–e106659. 27 indexed citations

18.

Carty, Shannon A., Mercy Gohil, Gary A. Koretzky, & Martha S. Jordan. (2014). TET2 Regulates CD8+ T Cell Differentiation. Blood. 124(21). 1423–1423.

19.

Lee, Jong-Seo, et al.. (2006). HES1 Cooperates With pRb to Activate RUNX2-Dependent Transcription. Journal of Bone and Mineral Research. 21(6). 921–933. 49 indexed citations

20.

Thomas, David M., Shannon A. Carty, Denise M. Piscopo, et al.. (2001). The Retinoblastoma Protein Acts as a Transcriptional Coactivator Required for Osteogenic Differentiation. Molecular Cell. 8(2). 303–316. 303 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact